Lifevantage Corp(LFVN)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

Lifevantage Corp (LFVN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores LFVN at 40.6/100 on a 32-signal composite quality model, placing it at rank #2,098 of 2,962 stocks — the bottom half of the AI-ranked universe. LFVN scores in the top quartile across earnings quality (84.7), balance sheet strength (78.4). Areas of concern include institutional flow (4.2) and revenue growth (13.8), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), Lifevantage Corp reports quarterly revenue of $42.4M, net income of $1.3M, an operating margin of 3.9%. Top institutional holders of LFVN by reported 13-F value include CAPITAL MANAGEMENT, RENAISSANCE TECHNOLOGIES, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. LFVN trades on the Nasdaq exchange and files with the SEC under CIK 849146. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate LFVN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Lifevantage Corp directly from SEC EDGAR.

AI Quality Score

40.6/100

AI Rank

#2,098

Revenue

$42.4M

Net Income

$1.3M

Free Cash Flow

$3.7M

Operating Margin

3.9%

LFVN key financials by period

Lifevantage Corp reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202610-K$182.6M$5.1M3.3%
FY 202510-K$228.5M$9.8M5.3%
FY 202410-K$200.2M$2.9M2.2%
FY 202310-K$213.4M$2.5M2.0%
FY 202210-K$206.4M$3.1M3.7%
FY 202110-K$220.2M$12.9M8.0%

Institutions holding LFVN

Institutional investors reporting a position in Lifevantage Corp on SEC Form 13F.
InstitutionSharesValueReported
CAPITAL MANAGEMENT1,878,411$11.7M2026-06-30
RENAISSANCE TECHNOLOGIES669,418$4.2M2026-06-30
VANGUARD CAPITAL MANAGEMENT429,203$2.7M2026-06-30
BlackRock268,605$1.7M2026-06-30
DIMENSIONAL FUND ADVISORS256,296$1.6M2026-06-30
ENVESTNET ASSET MANAGEMENT229,907$1.4M2026-06-30
SUSQUEHANNA INTERNATIONAL GROUP, LLP169,046$1.1M2026-06-30
AMERICAN CENTURY COMPANIES144,386$901.0K2026-06-30
JANE STREET GROUP138,056$861.5K2026-06-30
GEODE CAPITAL MANAGEMENT120,830$754.3K2026-06-30
LFVN

Lifevantage Corp

LFVN
NasdaqSmall CapHealthcare

13F Pro Quality Score

40.6/100

Rank #2,098 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

13.8/100

Profitability

38.0/100

Balance Sheet

78.4/100

Earnings Quality

84.7/100

Free Cash Flow

37.7/100

Institutional Flow

4.2/100

Revenue Scale

22.6/100

Dilution Risk

50.2/100

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Revenue

Q2 2026
EDGAR

$42.38M

Net Income

Q2 2026
EDGAR

$1.28M

EPS (Diluted)

Q2 2026
EDGAR

$0.10

Operating Margin

Q2 2026
EDGAR

3.9%

ROIC

Q2 2026
EDGAR

19.9%

Free Cash Flow

Q2 2026
EDGAR

$3.73M

Top Institutional Holders

as of Q2 2026
$38.77M total

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…